Page 0100

DISEASE-SPECIFIC CANCER CONTROL

102 CANCER CONTROL 2015

www.prolifica.eu). Dr J Howell is supported by an NHMRC

(Australia) Early Career Fellowship. l

Dr Jessica Howell, Dr Yusuke Shimakawa, Dr Shevanthi

Nayagam, Professor Simon Taylor-Robinson and Professor Mark

Thursz are members of the PROLIFICA research team based at

Imperial College, London, UK.

References

1.easl clinical practice guidelines: Management of chronic hepatitis B virus infection. J

Hepatol. 2012;57(1):167-85.

2.parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin.

2005;55(2):74-108.

3.parkin DM, Sitas F, Chirenje M, Stein L, Abratt R, Wabinga H. Part I: Cancer in

Indigenous Africans--burden, distribution, and trends. Lancet Oncol. 2008;9(7):683-92.

4.kirk GD, Lesi OA, Mendy M, Akano AO, Sam O, Goedert JJ, et al. The Gambia Liver

Cancer Study: Infection with hepatitis B and C and the risk of hepatocellular carcinoma

in West Africa. Hepatology. 2004;39(1):211-9.

5. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer

incidence and mortality worldwide: sources, methods and major patterns in

GLOBOCAN 2012. Int J Cancer 2015; 136(5): E359-86.

6.kirk GD, Lesi OA, Mendy M, Szymanska K, Whittle H, Goedert JJ, et al. 249(ser) TP53

mutation in plasma DNA, hepatitis B viral infection, and risk of hepatocellular

carcinoma. Oncogene. 2005;24(38):5858-67.

7.kuniholm MH, Lesi OA, Mendy M, Akano AO, Sam O, Hall AJ, et al. Aflatoxin exposure

and viral hepatitis in the etiology of liver cirrhosis in the Gambia, West Africa. Environ

Health Perspect. 2008;116(11):1553-7.

8.easl-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J

Hepatol. 2012;56(4):908-43.9.. Robotin MC, Kansil MQ, George J, Howard K, Tipper S,

Levy M, et al. Using a population-based approach to prevent hepatocellular cancer in

New South Wales, Australia: effects on health services utilisation. BMC health services

research. 2010;10:215.

10. Liaw YF, Sung JJ, Chow WC, Farrell G, Lee CZ, Yuen H, et al. Lamivudine for patients

with chronic hepatitis B and advanced liver disease. The New England journal of

medicine. 2004;351(15):1521-31.

11. Lopez PM, Villanueva A, Llovet JM. Systematic review: evidence-based management

of hepatocellular carcinoma--an updated analysis of randomized controlled trials.

Alimentary pharmacology & therapeutics. 2006;23(11):1535-47.

12. Poovorawan Y, Chongsrisawat V, Theamboonlers A, Srinivasa K, Hutagalung Y, Bock

HL, et al. Long-term benefit of hepatitis B vaccination among children in Thailand with

transient hepatitis B virus infection who were born to hepatitis B surface antigenpositive

mothers. J Infect Dis. 2009;200(1):33-8.

13. Poovorawan Y, Chongsrisawat V, Theamboonlers A, Leroux-Roels G, Kuriyakose S,

Leyssen M, et al. Evidence of protection against clinical and chronic hepatitis B infection

20 years after infant vaccination in a high endemicity region. J Viral Hepat.

2011;18(5):369-75.

14. Mendy M, Peterson I, Hossin S, Peto T, Jobarteh ML, Jeng-Barry A, et al.

Observational study of vaccine efficacy 24 years after the start of hepatitis B

vaccination in two Gambian villages: no need for a booster dose. PLoS One.

2013;8(3):e58029.

15. Montesano R. Hepatitis B immunization and hepatocellular carcinoma: The Gambia

Hepatitis Intervention Study. J Med Virol. 2002;67(3):444-6.

16. Chiang CJ, Yang YW, You SL, Lai MS, Chen CJ. Thirty-year outcomes of the national

hepatitis B immunization program in Taiwan. JAMA: the journal of the American Medical

Association. 2013;310(9):974-6.

17. Ekra D, Herbinger KH, Konate S, Leblond A, Fretz C, Cilote V, et al. A non-randomized

vaccine effectiveness trial of accelerated infant hepatitis B immunization schedules

with a first dose at birth or age 6 weeks in Cote d'Ivoire. Vaccine. 2008;26(22):2753-61.

18. Inskip HM, Hall AJ, Chotard J, Loik F, Whittle H. Hepatitis B vaccine in the Gambian

Expanded Programme on Immunisation: factors influencing antibody response. Int J

Epidemiol 1991; 20(3): 764-9.

19. Mendy M, Peterson I, Hossin S, Peto T, Jobarteh ML, Jeng-Barry A, et al.

Observational study of vaccine efficacy 24 years after the start of hepatitis B

vaccination in two Gambian villages: no need for a booster dose. PLoS One 2013; 8(3):

e58029.

20. Jemal A, Bray F, Forman D, O'Brien M, Ferlay J, Center M, et al. Cancer burden in

Africa and opportunities for prevention. Cancer. 2012.

21. Howell J, Lemoine M, Thursz M. Prevention of materno-foetal transmission of

hepatitis B in sub-Saharan Africa: the evidence, current practice and future challenges. J

Viral Hepat. 2014;21(6):381-96.

22. Shariff MI, Ladep NG, Cox IJ, Williams HR, Okeke E, Malu A, et al. Characterization of

urinary biomarkers of hepatocellular carcinoma using magnetic resonance

spectroscopy in a Nigerian population. J Proteome Res. 2010;9(2):1096-103.

23. Ladep NG, Dona AC, Lewis MR, Crossey MM, Lemoine M, Okeke E, et al. Discovery

and validation of urinary metabotypes for the diagnosis of hepatocellular carcinoma

(HCC) in West Africans. Hepatology. 2014.

24. Lemoine M, Shimakawa Y, Njie R, Njai HF, Nayagam S, Khalil M, et al. Food intake

increases liver stiffness measurements and hampers reliable values in patients with

chronic hepatitis B and healthy controls: the PROLIFICA experience in The Gambia.

Aliment Pharmacol Ther. 2014;39(2):188-96.

25. Lemoine M, Shimakawa Y, Goldin R, Khalil M, Lloyd J, Suso P,

Nayagam S, Freeya Njai H, Taal M, Ndow G, D'Alessandro U, Njie R, Thursz M. Validation

and comparison of non-invasive markers of liver fibrosis in West African patients with

chronic hepatitis B living in The Gambia. J Hepatol 2014; 60(suppl 1): S414

26. Shimakawa Y, Bottomley C, Njie R, Mendy M. The association between maternal

hepatitis B e antigen status, as a proxy for perinatal transmission, and the risk of

hepatitis B e antigenaemia in Gambian children. BMC Public Health. 2014;14:532.Y.

Shimakawa,

27. Lemoine M, Freeya Njai H, Jatta A, Sanneh B, Taal M, Corrah MT,

D'Alessandro U, Njie R, Thursz M. Community-based screening for hepatitis B virus

infection in The Gambia, West Africa: prevalence of infection and factors affecting the

screening attendance. J Hepatol 2013; 58(Supp1): S21.

28. Lemoine M, Njai H, Shimakawa Y, Taal M, Corrah T,

D'Alessandro U, Njie R, Thursz M. Rural and urban community-based hepatitis B

screening in The Gambia: Assessment of liver disease reveals a significant proportion of

eligible patients for antiviral therapy. J Hepatol 2013; 58(suppl 1): S402

29. Shimakawa Y, Takao Y, Anderson ST, Taal M, Yamaguchi T, Giana L, et al. The

prevalence and burden of symptoms in patients with chronic liver diseases in The

Gambia, West Africa. Palliat Med. 2014.

30. Shimakawa Y, Yan HJ, Tsuchiya N, Bottomley C, Hall AJ. Association of early age at

establishment of chronic hepatitis B infection with persistent viral replication, liver

cirrhosis and hepatocellular carcinoma: a systematic review. PLoS One.

2013;8(7):e69430.

31. Lok AS, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology.

2009;50(3):661-2.

32. Nayagam S, Shimakawa Y, Lemoine M, Njie R, Tamba S, et al. Feasibility and cost

analysis of community based hepatitis B screening programme in Sub-Saharan Africa. J

Hepatol 2014; 60: S36.

33. Ladep NG, Dona AC, Lewis MR, Crossey MM, Lemoine M, Okeke E, et al. Discovery

and validation of urinary metabotypes for the diagnosis of hepatocellular carcinoma in

West Africans. Hepatology. 2014;60(4):1291-301.

34. Xiao G, Yang J, Yan L. Comparison of Diagnostic accuracy of APRI and FIB-4 for

detecting liver fibrosis in adult patients with chronic hepatitis B virus infection: A

systemic review and meta-analysis. Hepatology. 2014.

Index

  1. Page 0001
  2. Page 0002
  3. Page 0003
  4. Page 0004
  5. Page 0005
  6. Page 0006
  7. Page 0007
  8. Page 0008
  9. Page 0009
  10. Page 0010
  11. Page 0011
  12. Page 0012
  13. Page 0013
  14. Page 0014
  15. Page 0015
  16. Page 0016
  17. Page 0017
  18. Page 0018
  19. Page 0019
  20. Page 0020
  21. Page 0021
  22. Page 0022
  23. Page 0023
  24. Page 0024
  25. Page 0025
  26. Page 0026
  27. Page 0027
  28. Page 0028
  29. Page 0029
  30. Page 0030
  31. Page 0031
  32. Page 0032
  33. Page 0033
  34. Page 0034
  35. Page 0035
  36. Page 0036
  37. Page 0037
  38. Page 0038
  39. Page 0039
  40. Page 0040
  41. Page 0041
  42. Page 0042
  43. Page 0043
  44. Page 0044
  45. Page 0045
  46. Page 0046
  47. Page 0047
  48. Page 0048
  49. Page 0049
  50. Page 0050
  51. Page 0051
  52. Page 0052
  53. Page 0053
  54. Page 0054
  55. Page 0055
  56. Page 0056
  57. Page 0057
  58. Page 0058
  59. Page 0059
  60. Page 0060
  61. Page 0061
  62. Page 0062
  63. Page 0063
  64. Page 0064
  65. Page 0065
  66. Page 0066
  67. Page 0067
  68. Page 0068
  69. Page 0069
  70. Page 0070
  71. Page 0071
  72. Page 0072
  73. Page 0073
  74. Page 0074
  75. Page 0075
  76. Page 0076
  77. Page 0077
  78. Page 0078
  79. Page 0079
  80. Page 0080
  81. Page 0081
  82. Page 0082
  83. Page 0083
  84. Page 0084
  85. Page 0085
  86. Page 0086
  87. Page 0087
  88. Page 0088
  89. Page 0089
  90. Page 0090
  91. Page 0091
  92. Page 0092
  93. Page 0093
  94. Page 0094
  95. Page 0095
  96. Page 0096
  97. Page 0097
  98. Page 0098
  99. Page 0099
  100. Page 0100
  101. Page 0101
  102. Page 0102
  103. Page 0103
  104. Page 0104
  105. Page 0105
  106. Page 0106
  107. Page 0107
  108. Page 0108
  109. Page 0109
  110. Page 0110
  111. Page 0111
  112. Page 0112
  113. Page 0113
  114. Page 0114
  115. Page 0115
  116. Page 0116
  117. Page 0117
  118. Page 0118
  119. Page 0119
  120. Page 0120
  121. Page 0121
  122. Page 0122
  123. Page 0123
  124. Page 0124
  125. Page 0125
  126. Page 0126
  127. Page 0127
  128. Page 0128
  129. Page 0129
  130. Page 0130
  131. Page 0131
  132. Page 0132
  133. Page 0133
  134. Page 0134
  135. Page 0135
  136. Page 0136
  137. Page 0137
  138. Page 0138
  139. Page 0139
  140. Page 0140
  141. Page 0141
  142. Page 0142
  143. Page 0143
  144. Page 0144
  145. Page 0145
  146. Page 0146
  147. Page 0147
  148. Page 0148
  149. Page 0149
  150. Page 0150
  151. Page 0151
  152. Page 0152
  153. Page 0153
  154. Page 0154

powered by PageTiger